1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. KOBO BIOTECH LTD.
Kobo Biotech Ltd. BSE: 531541 | GSM
2.25 0.07 (3.21%)
11,033
BSE Volume

BSE 19 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert



Board Meetings - Kobo Biotech Ltd.

The latest board meeting for Kobo Biotech Ltd. took place on 14 Aug 2024, for the purpose of Quarterly Results

Ex-date Purpose Notes
14 Aug 2024 Quarterly Results -
30 May 2024 Audited Results -
14 Feb 2024 Quarterly Results -
10 Nov 2023 Quarterly Results -
11 Aug 2023 Quarterly Results -
30 May 2023 Audited Results -
13 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
11 Aug 2022 Quarterly Results -
30 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
08 Nov 2021 Quarterly Results -
13 Aug 2021 Quarterly Results -
30 Jun 2021 Audited Results -
12 Feb 2021 Quarterly Results -
13 Nov 2020 Quarterly Results -
15 Sep 2020 Quarterly Results -
30 Jun 2020 Audited Results -
14 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
14 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Quarterly Results -
30 May 2018 Audited Results -
14 Feb 2018 Quarterly Results -
14 Dec 2017 Quarterly Results -
14 Sep 2017 Quarterly Results -
30 May 2017 Audited Results -
14 Feb 2017 Quarterly Results & Others The Company had issued 1,05,00,000 Share warrants @ Rs. 26 per share warrant.
11 Nov 2016 Quarterly Results -
29 Oct 2016 Quarterly Results -
12 Feb 2016 Quarterly Results -
06 Nov 2015 Quarterly Results -
12 Aug 2015 Others Allotted 1,05,00,000 (One Crore Five Lacs) Warrants convertible into equal number of equity shares of Rs. 10/- each at an issue price of Rs. 26/- each (including premium of Rs.16/- each).
05 Aug 2015 Quarterly Results Approved a Change in Designation of Mr. Manoj Jain as Whole Time Director on the Board of the Company.
09 Jun 2015 Issue of Securities -
29 May 2015 Audited Results -
16 Apr 2015 Appointment of Secretary & Others Authorize Mr. Manoj Jain, Director and / or Mr.Jignesh Patel, Company Secretary of the Company.
04 Feb 2015 Quarterly Results -
07 Nov 2014 Quarterly Results -
14 Aug 2014 Quarterly Results -
30 May 2014 Audited Results -
14 Feb 2014 Quarterly Results -
12 Nov 2013 Quarterly Results -
09 Aug 2013 Quarterly Results -
30 May 2013 Audited Results -
14 Feb 2013 Quarterly Results -
14 Nov 2012 Quarterly Results -
13 Aug 2012 Quarterly Results -
30 May 2012 Audited Results & Dividend -
13 Feb 2012 Quarterly Results -
14 Nov 2011 Quarterly Results -
29 Jul 2011 Quarterly Results -
19 May 2011 Audited Results & Dividend -
14 Feb 2011 Quarterly Results -
30 Oct 2010 Quarterly Results -
13 Aug 2010 Quarterly Results & Dividend -
08 Jul 2010 Audited Results -
15 May 2010 Quarterly Results -
30 Jan 2010 Quarterly Results -
31 Oct 2009 Quarterly Results -
27 Aug 2009 Audited Results -
31 Jul 2009 Quarterly Results -
30 Apr 2009 Quarterly Results -
31 Jan 2009 Quarterly Results & Others To approve the transfer of equity shares accepted in the Avon Organics Ltd Open Offer in favour of Arch Pharmalabs Ltd, increasing the stake in the Company to 63.60%.
31 Jul 2008 Quarterly Results -
30 Jun 2008 Audited Results -
30 Jan 2008 Quarterly Results -
03 Nov 2007 Preferential Issue of Equity Shares To consider Preferential Issue of Equity Shares.
30 Oct 2007 Quarterly Results -
27 Jul 2007 Quarterly Results -
30 Jun 2007 Audited Results -
29 Jan 2007 Quarterly Results -
31 Oct 2006 Quarterly Results -
29 Jul 2006 Quarterly Results -
30 Jun 2006 Accounts -
30 Jan 2006 Quarterly Results & Preferential Issue Preferential Issue of shares, Issue of 30,00,000 equity shares.
29 Oct 2005 Quarterly Results -
23 Jul 2005 Quarterly Results -
30 Jun 2005 Accounts -
31 Jan 2005 Quarterly Results -
31 Dec 2004 Right Issue of Equity Shares To consider equity shares/warrants on preferential basis.
28 Oct 2004 Quarterly Results -
30 Jun 2004 Accounts -
10 Mar 2004 Others Allotment of 4,80,000 convertible warrants to promoters and Directors, on preferential basis.
31 Jan 2004 Quarterly Results -
12 Nov 2003 Others To interalia propose a preferential allotment of equity shares of the company in accordance with the SEBI Guidlines.
31 Oct 2003 Quarterly Results -
31 Jul 2003 Quarterly Results -
28 Jun 2003 Accounts -
31 Jan 2003 Quarterly Results -
31 Oct 2002 Half Yearly Results & Quarterly Results -
27 Jul 2002 Quarterly Results -
29 Jun 2002 Accounts -
30 Jan 2002 Quarterly Results -
31 Oct 2001 Quarterly Results -
16 Jul 2001 Quarterly Results -
30 Jun 2001 Accounts -